Skip to main content
Log in

Fission yeast tmsl protein abrogates normal development in Xenopus laevis embryos

  • Short Communication
  • Published:
Roux's archives of developmental biology Aims and scope Submit manuscript

Abstract

Recently we cloned tms1 (a putative dehydrogenase) by complementation of a human tumour-derived mutant p53 induced growth arrest in fission yeast. Microinjection of purified tmsl protein into Xenopus laevis embryos abrogated normal embryo development by causing cleavage retardation or cleavage arrest of injected blastomeres in a concentration dependant manner, whereas injection of specific affinity purified tms1 antiserum showed no significant morphological defects. Microinjection of tms1 protein together with affinity purified tms1 antibody resulted in a significantly reduced number of cleavage arrested embryos.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Appel K, Schneider E, Wagner P, Höög JO, Karlsson C, Montenarh M (1994) A new 42 kDa protein binding to the growth suppressor protein p53. Int J Oncol 5:667–673

    Google Scholar 

  • Cross F, Roberst J, Weintraub H (1989) Simple and complex cell cycle. Annu Rev Cell Biol 5:341–395

    PubMed  Google Scholar 

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221

    Article  PubMed  Google Scholar 

  • Duester G, Jörnvall H, Hatfield GW (1986) Intron-dependent evolution of the nucleotide-binding domains within alcohol dehydrogenase and related enzymes. Nucleic Acids Res 5:1931–1941

    Google Scholar 

  • Finlay CA, Hinds PW, Levine AJ (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093

    PubMed  Google Scholar 

  • Hinds P, Finlay C, Levine AJ (1989) Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 63:739–746

    PubMed  Google Scholar 

  • Hochuli E, Bannwarth W, Döbeli H, Gentz R, Stüber D (1988) Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Biotechnology 1321–1325

  • Hoever M, Clement JH, Wedlich D, Montenarh M, Knöchel W (1994) Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene 9:109–120

    PubMed  Google Scholar 

  • Lane DP (1992) Cancer: p53, guardian of the genome. Nature 358:15–16

    Article  PubMed  Google Scholar 

  • Levine AJ (1993) The tumor suppressor genes. Annu Rev Biochem 62:623–651

    Article  PubMed  Google Scholar 

  • Mercer WE, Shields MT, Amin M, Sauve GJ, Appela E, Romano JW, Ullrich SJ (1990) Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Nail Acad Sci USA 87:6166–6170

    Google Scholar 

  • Michalovitz D, Halevy O, Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671–680

    Article  PubMed  Google Scholar 

  • Montenarh M (1992) Functional implications of the growth-suppressor/oncoprotein p53 (review). Int J Oncol 1:37–45

    Google Scholar 

  • Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61:441–470

    Article  CAS  PubMed  Google Scholar 

  • Soussi T, Caron de Fromentel C, May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945–952

    PubMed  Google Scholar 

  • Studier FW Rosenberg AH, Dunn JJ, Dubendorff JW (1990) Use of T7 RNA polymerase to direct the expression of cloned genes. Methods Enzymol 185:60–89

    PubMed  Google Scholar 

  • Wagner P (1994) p53 forms tight complexes with tmsl of fission yeast. Int J Oncol 4:987–992

    Google Scholar 

  • Wagner P, Montenarh M (1994) GI control of the eukaryotic cell cycle. In: Spandidos D (ed) Current perspectives on molecular and cellular oncology. Jai Press Ltd., London, in press

    Google Scholar 

  • Wagner P, Simanis V, Maimets T, Keenan E, Addison C, Brain R, Grimaldi M, Stürzbecher HW Jenkins JR (1991) A human tumour-derived mutant p53 protein induces a p34. reversible growth arrest in fission yeast. Oncogene 6:1539–1547

    PubMed  Google Scholar 

  • Wagner P, Hengst L, Gallwitz D (1992) YPT proteins in yeast. Methods Enzymol 219:369–387

    PubMed  Google Scholar 

  • Wagner P, Grimaldi M, Jenkins JR (1993) Putative dehydrogenase tmsl suppresses growth arrest induced by a p53 tumour mutant in fission yeast. Eur J Biochem 217:731–736

    PubMed  Google Scholar 

  • Wolf D, Admon S, Oren M, Rotter V (1984) Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species. Mol Cell Biol 4:552–558

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, P., Hoever, M., Appel, K. et al. Fission yeast tmsl protein abrogates normal development in Xenopus laevis embryos. Roux's Arch Dev Biol 204, 198–202 (1995). https://doi.org/10.1007/BF00241273

Download citation

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00241273

Keywords

Navigation